Sectors
BDMD
Baird Medical Investment Holdings Limited
1.06
5 x 1.04
11 x 1.15
bid
ask
-
0.03
2.75%
11:01 AM
timesize
| Ytd | -22.06% | |
| 1y | -51.15% |
1.06
day range
1.15
0.76
52 week range
3.75
| Open | 1.09 | Prev Close | 1.09 | Low | 1.06 | High | 1.15 | Mkt Cap | 44.67M |
| Vol | 8.32K | Avg Vol | 139.99K | EPS | -0.94 | P/E | -1.16 | Forward P/E | N/A |
| Beta | -1.17 | Short Ratio | 0.72 | Inst. Own | 0.99% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-15 | 50-d Avg | 1.31 | 200-d Avg | 1.52 | 1yr Est | 0.00 |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
Baird Medical Investment Holdings Limited, together with its subsidiaries develops and sells microwave ablation medical devices for minimally invasive tumor treatment in China. The company's medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Baird Medical Investment Holdings Limited was founded in 2012 and is headquartered in Guangzhou, China.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2023-10-24 | EXCELFIN SPAC LLC | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Conversion of Exercise of derivative security |
| 2023-05-10 | HIGHBRIDGE CAPITAL MANAGEMENT LLC | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Sale |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | Fidelity NASDAQ Composite Index Fund | 5.85K | 10.33K | 0.02% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|